Drugs / Black chokeberry extract
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT06486623 | Mar → Dec 2023 | disorder of iron metabolism and transport | Poznan University of Physical Education | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT06903195 | Mar → Dec 2023 | disorder of defective peroxisome oxidative status | Poznan University of Physical Education | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Black chokeberry extract | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06903195 ↗ |
| Route | Oral | “The swimmers sipped each capsule with glass of water.” NCT06486623 ↗ |